Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
36.73
USD
+0.03 (+0.08%)
Official Closing Price
Updated: 7:59 PM EST, Jan 19, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Pfizer
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Pfizer to Present Data from Its Hematology Portfolio at the 52nd Annual Meeting of the American Society of Hematology
November 29, 2010
Company to Present Phase 3 Data Studying Bosutinib in Chronic Myeloid Leukemia
From
PR Newswire
Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease
November 28, 2010
From
PR Newswire
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.
November 22, 2010
From
PR Newswire
The NASDAQ OMX CRD Global Sustainability 50 Index Expands to 100 Companies and Releases Semi-Annual Evaluation Results
November 21, 2010
From
GlobeNewswire News Releases
Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
November 18, 2010
Detailed Study Results Expected to be Presented at an Upcoming Medical Meeting
From
PR Newswire
APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued
November 18, 2010
From
Business Wire News Releases
Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds
November 16, 2010
Survey Reports Nearly 70 Percent of People Avoid Crowded Areas During the Holidays(1)
From
PR Newswire
Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
November 16, 2010
Anthony J. Coyle, Ph.D. Will Head the Network that Aims to Accelerate and Transform Drug Discovery and Development
From
PR Newswire
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
November 14, 2010
Rates of Heart Failure Hospitalization, All-Cause Hospitalization, and All-Cause Mortality also Significantly Reduced
From
PR Newswire
Lower Protein in Infant Formula Supports Growth Rate Similar to Breast Milk, New Study Shows
November 09, 2010
From
PR Newswire
Biovista Announces a Drug Repositioning Collaboration With Pfizer
November 09, 2010
From
PR Newswire
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease
November 09, 2010
- Alan Arnette, Caregiver to His Mother, Now Dedicates Challenging Climbs to Her Memory and Others Caring for Alzheimer's Patients -
From
PR Newswire
S&P Equity Research Services Publishes Quality Trends, an In-Depth Analysis of 'Quality' in the Equity Markets
November 08, 2010
S&P Recommends Investors Begin Rotating Into High Quality Ranking Issues Now
From
PR Newswire
Progenics Pharmaceuticals Announces Third Quarter 2010 Financial Results
November 08, 2010
From
Business Wire News Releases
In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function
November 07, 2010
Tasocitinib Demonstrates Sustained Efficacy at 24 Months in Phase 2/3 Open Label Extension Study
From
PR Newswire
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
November 06, 2010
Collaboration Aims to Empower Patients with Psoriatic Arthritis and Rheumatoid Arthritis to Seek Care
From
PR Newswire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
November 03, 2010
From
PR Newswire
Pfizer Reports Third-Quarter 2010 Results
November 02, 2010
From
PR Newswire
Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
October 28, 2010
First Treatment Approved for Common Pain Conditions Filling Important Unmet Need for Patients in Japan
From
PR Newswire
Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend
October 28, 2010
From
PR Newswire
Critical Alerts for Amazon.com, Pfizer, Motorola, Pioneer Natural Resources, and CB Richard Ellis Released by Seven Summits Research
October 28, 2010
From
PR Newswire
Pain Therapeutics Reports Third Quarter 2010 Financial Results
October 28, 2010
From
GlobeNewswire News Releases
Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Cri
October 27, 2010
First-in-Class ALK Inhibitor Rapidly Advanced to Phase 3 Development
From
PR Newswire
Pain Therapeutics Declares Special One-Time Cash Distribution to Shareholders
October 27, 2010
From
GlobeNewswire News Releases
Wall Street News Alert: Hot Stock to Watch: Unity Management Group -- October 27, 2010
October 27, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
From
Marketwired News Releases
Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
October 22, 2010
From
PR Newswire
New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia
October 21, 2010
Findings From Largest MRSA Nosocomial Pneumonia Study Conducted to Date Were Presented During IDSA Annual Meeting
From
PR Newswire
Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
October 20, 2010
Phase III Treatment-naive and Treatment-experienced Trials Underway for S/GSK1349572 ('572)
From
PR Newswire
Centrum® Encourages Women to Pledge to Take Time for Life's Greatest Pleasures
October 20, 2010
Survey Finds That Lack of Energy is Taking its Toll on Lifestyles of Nearly Three-Quarters of Women(1)
From
PR Newswire
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
October 20, 2010
Transaction will expand portfolio of generic medicines in Brazil
From
PR Newswire
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.